On the mechanisms and putative pathways involving neuroimmune interactions

Biochemical and Biophysical Research Communications

Volumn 370, Issue 4, 2008, Pages 531-535

  Haddad, John J ^a,b  

^a School of Arts and Sciences   (Lebanon)

^b UNIVERSITY OF BALAMAND   (Lebanon)

Author keywords

Brain; CNS; Cytokine; HPA; Inflammation; Neuroimmunology; Neuropeptide; Neurotransmitters

Indexed keywords

ANDROGEN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYTOKINE; ENDORPHIN; ENKEPHALIN; ESTROGEN; GLUCOCORTICOID; LIGAND; LYMPHOKINE; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTRANSMITTER; SOMATOSTATIN; SUBSTANCE P; TACHYKININ; THIOREDOXIN; THYMOSIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; MOLECULAR INTERACTION; NEUROIMMUNOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHWANN CELL; SHORT SURVEY; STRESS; T LYMPHOCYTE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; NEUROIMMUNOMODULATION;

EID: 46349083075     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.012     Document Type: Short Survey

References (43)

1. Haddad J.J., Saadé N.E., and Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J. Neuroimmunol. 133 (2002) 1-19
2. Correa S.G., Maccioni M., Rivero V.E., Iribarren P., Sotomayor C.E., and Riera C.M. Cytokines and the immune-neuroendocrine network: what did we learn from infection and autoimmunity?. Cytokine Growth Factor Rev. 18 (2007) 125-134
3. Engelhardt B. Regulation of immune cell entry into the central nervous system. Results Probl. Cell Differ. 43 (2006) 259-280
4. Galea I., Bechmann I., and Perry V.H. What is immune privilege (not)?. Trends Immunol. 28 (2007) 12-18
5. Carson M.J., Doose J.M., Melchior B., Schmid C.D., and Ploix C.C. CNS immune privilege: hiding in plain sight. Immunol. Rev. 213 (2006) 48-65
6. Biber K., de Jong E.K., van Weering H.R., and Boddeke H.W. Chemokines and their receptors in central nervous system disease. Curr. Drug Targets 7 (2006) 29-46
7. Neumann H. Control of glial immune function by neurons. Glia 36 (2001) 191-199
8. Haddad J.J. On the enigma of pain and hyperalgesia: a molecular perspective. Biochem. Biophys. Res. Commun. 353 (2007) 217-224
9. Haddad J.J. Cellular and molecular regulation of inflammatory pain, nociception and hyperalgesia--the role of the transcription factor NF-κB as the lynchpin nocicensor: hyperalgesic or analgesic effect?. Curr. Immunol. Rev. 3 (2007) 117-131
10. Kopp E.B., and Medzhitov R. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11 (1999) 13-18
11. Gisler R.H., and Schenkel-Hulliger L. Hormonal regulation of the immune response. II. Influence of pituitary and adrenal activity on immune responsiveness in vitro. Cell Immunol. 2 (1971) 646-657
12. Jansson L., and Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm. Res. 47 (1998) 290-301
13. Wekerle H., Schwab M., Linington C., and Meyermann R. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur. J. Immunol. 16 (1986) 1551-1557
14. Ader R., and Cohen N. Behaviorally conditioned immunosuppression. Psychosom. Med. 37 (1975) 333-340
15. Renoux G., Biziere K., Renoux M., Guillaumin J.M., and Degenne D. A balanced brain asymmetry modulates T cell-mediated events. J. Neuroimmunol. 5 (1983) 227-238
16. D. Tischner, H.M. Reichardt, Glucocorticoids in the control of neuroinflammation, Mol. Cell. Endocrinol., in press.
17. King B.M., Zansler C.A., Tatford III A.C., Neville K.L., Sam H., Kass J.M., and Dallman M.F. Level of corticosterone replacement determines body weight gain in adrenalectomized rats with VMH lesions. Physiol. Behav. 54 (1983) 1187-1190
18. Oberbeck R. Catecholamines: physiological immunomodulators during health and illness. Curr. Med. Chem. 13 (2006) 1979-1989
19. Romano T.A., Felten S.Y., Felten D.L., and Olschowka J.A. Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide. Brain Behav. Immun. 5 (1991) 116-131
20. Rouveix B. Clinical pharmacology of cytokines. Clinical pharmacology of cytokines. Eur. Cytokine Netw. 8 (1997) 291-293
21. Saadé N.E., Abou Jaoude P.G., Saadeh F.A., Hamoui S., Safieh-Garabedian B., Kanaan S.A., Atweh S.F., and Jabbur S.J. Fos-like immunoreactivity induced by intraplantar injection of endotoxin and its reduction by morphine. Brain Res. 769 (1997) 57-65
22. Safieh-Garabedian B., Kanaan S.A., Haddad J.J., Abou Jaoude P., Jabbur S.J., and Saadé N.E. Involvement of interleukin-1β, nerve growth factor and prostaglandin E2 in endotoxin-induced localized inflammatory hyperalgesia. Br. J. Pharmacol. 121 (1997) 1619-1626
23. Dinarello C.A. Pro-inflammatory cytokines. Chest 118 (2000) 503-508
24. Haddad J.J., and Land S.C. O2-evoked regulation of HIF-1α and NF-κB in perinatal lung epithelium requires glutathione biosynthesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 278 (2000) L492-L503
25. Haddad J.J., and Land S.C. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-κB (RelA)-selective targeting. Biochem. Biophys. Res. Commun. 271 (2000) 257-267
26. Haddad J.J., and Land S.C. Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-α biosynthesis. Br. J. Pharmacol. 135 (2002) 520-536
27. Haddad J.J., and Land S.C. Amiloride blockades lipopolysaccharide-induced cytokine biosynthesis in an IκB-α/NF-κB-dependent mechanism: evidence for the amplification of an anti-inflammatory pathway in the alveolar epithelium. Am. J. Respir. Cell Mol. Biol. 26 (2002) 114-126
28. Haddad J.J., and Fahlman C.S. Redox- and oxidant-mediated regulation of interleukin-10: an anti-inflammatory, antioxidant cytokine?. Biochem. Biophys. Res. Commun. 297 (2002) 163-176
29. Haddad J.J., and Harb H.L. Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α. Int. Immunopharmacol. 5 (2005) 461-483
30. Haddad J.J., and Harb H.L. l-γ-Glutamyl-l-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?. Mol. Immunol. 42 (2005) 987-1014
31. Haddad J.J., Olver R.E., and Land S.C. Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity: evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J. Biol. Chem. 275 (2000) 21130-21139
32. Haddad J.J., Safieh-Garabedian B., Saadé N.E., Kanaan S.A., and Land S.C. Chemioxyexcitation (ΔpO2/ROS) dependent release of IL-1β, IL-6 and TNF-α: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium. Cytokine 13 (2001) 138-147
33. Haddad J.J., Safieh-Garabedian B., Saadé N.E., and Land S.C. Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium. J. Pharmacol Exp. Therap. 296 (2001) 996-1005
34. Haddad J.J., Lauterbach R., Saadé N.E., Safieh-Garabedian B., and Land S.C. α-Melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor-κB translocation and activation: evidence for involvement of an interleukin-1β193-195 receptor antagonism in the alveolar epithelium. Biochem. J. 355 (2001) 29-38
35. Haddad J.J., Saadé N.E., and Safieh-Garabedian B. Redox regulation of TNF-α biosynthesis: augmentation by irreversible inhibition of γ-glutamylcysteine synthetase and the involvement of an IκB-α/NF-κB-independent pathway in alveolar epithelial cells. Cell Signal. 14 (2002) 211-218
36. Safieh-Garabedian B., Jalakhian R.H., Saadé N.E., Haddad J.J., Jabbur S.J., and Kanaan S.A. Thymulin reduces hyperalgesia induced by peripheral endotoxin injection in rats and mice. Brain Res. 717 (1996) 179-183
37. Safieh-Garabedian B., Poole S., Haddad J.J., Massaad C.A., Jabbur S.J., and Saadé N.E. The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology 42 (2002) 864-872
38. Bumiller A., Gotz F., Rohde W., and Dorner G. Effects of repeated injections of interleukin 1β or lipopolysaccharide on the HPA axis in the newborn rat. Cytokine 11 (1999) 225-230
39. Jones T.H., and Kennedy R.L. Cytokines and hypothalamic-pituitary function. Cytokine 5 (1993) 531-538
40. Makino Y., Okamoto K., Yoshikawa N., Aoshima M., Hirota K., Yodoi J., Umesono K., Makino I., and Tanaka H. Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J. Clin. Invest. 98 (1996) 2469-2477
41. Lezoualc'h F., Engert S., Berning B., and Behl C. Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid β precursor protein and with the suppression of nuclear factor-κB. Mol. Endocrinol. 14 (2000) 147-159
42. Pedersen W.A., McCullers D., Culmsee C., Haughey N.J., Herman J.P., and Mattson M.P. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 8 (2001) 492-503
43. Wissink S., Meijer O., Pearce D., van Der Burg B., and van Der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 275 (2000) 1321-1326